These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31120393)

  • 21. Autoimmune rheumatic diseases.
    Anaya JM; Shoenfeld Y; Buttgereit F; Gonzalez-Gay MA
    Biomed Res Int; 2014; 2014():952159. PubMed ID: 25162038
    [No Abstract]   [Full Text] [Related]  

  • 22. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus.
    Takeshima Y; Iwasaki Y; Fujio K; Yamamoto K
    Semin Arthritis Rheum; 2019 Jun; 48(6):1142-1145. PubMed ID: 31056210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.
    Cunningham M; Marks N; Barnado A; Wirth JR; Gilkeson G; Markiewicz M
    Semin Thromb Hemost; 2014 Sep; 40(6):675-81. PubMed ID: 25173498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
    Blanco LP; Kaplan MJ
    PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
    Miyagaki T; Fujimoto M; Sato S
    Int Immunol; 2015 Oct; 27(10):495-504. PubMed ID: 25957264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of A20 in autoimmune diseases.
    Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
    Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vitamin D and autoimmunity. Second part: Clinical aspects].
    Schoindre Y; Terrier B; Kahn JE; Saadoun D; Souberbielle JC; Benveniste O; Amoura Z; Piette JC; Cacoub P; Costedoat-Chalumeau N
    Rev Med Interne; 2012 Feb; 33(2):87-93. PubMed ID: 22209319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyses of immunosenescent markers in patients with autoimmune disease.
    Thewissen M; Somers V; Venken K; Linsen L; van Paassen P; Geusens P; Damoiseaux J; Stinissen P
    Clin Immunol; 2007 May; 123(2):209-18. PubMed ID: 17317320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation.
    Okano T; Saegusa J; Nishimura K; Takahashi S; Sendo S; Ueda Y; Morinobu A
    Sci Rep; 2017 Feb; 7():42412. PubMed ID: 28186160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone Posttranslational Modifications of CD4⁺ T Cell in Autoimmune Diseases.
    Wang Z; Yin H; Lau CS; Lu Q
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of Egr-2 in autoimmune diseases.
    Zhang M; Wang Y; Wang JS; Liu J; Liu MM; Yang HB
    Inflammation; 2015; 38(3):972-7. PubMed ID: 25381473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells.
    Lai NS; Koo M; Yu CL; Lu MC
    Clin Exp Immunol; 2017 Mar; 187(3):327-336. PubMed ID: 27880973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic dynamics in immunity and autoimmunity.
    Zhao M; Wang Z; Yung S; Lu Q
    Int J Biochem Cell Biol; 2015 Oct; 67():65-74. PubMed ID: 26026281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders.
    Pankratz S; Bittner S; Kehrel BE; Langer HF; Kleinschnitz C; Meuth SG; Göbel K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.